Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2002 1
2003 1
2004 1
2005 1
2010 1
2011 1
2012 2
2013 1
2015 1
2016 4
2017 7
2018 11
2019 11
2020 8
2021 10
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Systemic Therapy for Melanoma: ASCO Guideline.
Seth R, Messersmith H, Kaur V, Kirkwood JM, Kudchadkar R, McQuade JL, Provenzano A, Swami U, Weber J, Alluri KC, Agarwala S, Ascierto PA, Atkins MB, Davis N, Ernstoff MS, Faries MB, Gold JS, Guild S, Gyorki DE, Khushalani NI, Meyers MO, Robert C, Santinami M, Sehdev A, Sondak VK, Spurrier G, Tsai KK, van Akkooi A, Funchain P. Seth R, et al. Among authors: funchain p. J Clin Oncol. 2020 Nov 20;38(33):3947-3970. doi: 10.1200/JCO.20.00198. Epub 2020 Mar 31. J Clin Oncol. 2020. PMID: 32228358
Clinical Trials in Metastatic Uveal Melanoma: Current Status.
Sussman TA, Funchain P, Singh A. Sussman TA, et al. Among authors: funchain p. Ocul Oncol Pathol. 2020 Dec;6(6):381-387. doi: 10.1159/000508383. Epub 2020 Sep 10. Ocul Oncol Pathol. 2020. PMID: 33447587 Free PMC article. Review.
The Microbiome of Temporal Arteries.
Hoffman GS, Getz TM, Padmanabhan R, Villa-Forte A, Clifford AH, Funchain P, Sankunny M, Perry JD, Blandford A, Kosmorsky G, Lystad L, Calabrese LH, Eng C. Hoffman GS, et al. Among authors: funchain p. Pathog Immun. 2019 Feb 12;4(1):21-38. doi: 10.20411/pai.v4i1.270. eCollection 2019. Pathog Immun. 2019. PMID: 30993251 Free PMC article.
Immune Check Point Inhibitor-Associated Glomerulonephritis.
Ashour T, Nakhoul G, Patil P, Funchain P, Herlitz L. Ashour T, et al. Among authors: funchain p. Kidney Int Rep. 2018 Oct 29;4(2):355-359. doi: 10.1016/j.ekir.2018.10.017. eCollection 2019 Feb. Kidney Int Rep. 2018. PMID: 30775635 Free PMC article. No abstract available.
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Meyskens FL Jr, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB. Jeter JM, et al. Among authors: funchain p. Cancer. 2019 Jan 1;125(1):18-44. doi: 10.1002/cncr.31719. Epub 2018 Oct 3. Cancer. 2019. PMID: 30281145 Free PMC article. Review.
55 results